Marianne Hupé, Xavier Roblin, David Laharie. Editorial: Taking a Different Route–Navigating the Switch From Intravenous to Subcutaneous Vedolizumab. Authors' Reply. // Alimentary Pharmacology and Therapeutics. – 2026. – DOI: 10.1111/apt.71069. – URL: https://onlinelibrary.wiley.com/doi/10.1111/apt.71069?af=R
Marianne Hupé, Xavier Roblin, & David Laharie (2026). Editorial: Taking a Different Route–Navigating the Switch From Intravenous to Subcutaneous Vedolizumab. Authors' Reply. Alimentary Pharmacology and Therapeutics. https://doi.org/10.1111/apt.71069
Marianne Hupé, et al. “Editorial: Taking a Different Route–Navigating the Switch From Intravenous to Subcutaneous Vedolizumab. Authors' Reply.” Alimentary Pharmacology and Therapeutics, 2026. doi:10.1111/apt.71069.
@article{Hup2026,
title = {Editorial: Taking a Different Route–Navigating the Switch From Intravenous to Subcutaneous Vedolizumab. Authors' Reply},
author = {Hupé, Marianne and Roblin, Xavier and Laharie, David},
journal = {Alimentary Pharmacology and Therapeutics},
year = {2026},
doi = {10.1111/apt.71069},
url = {https://onlinelibrary.wiley.com/doi/10.1111/apt.71069?af=R}
}